# Is NMES Treatment in Sepsis/ Septic Shock Patients Protective in Development of ICU-AW?

> **NCT04833621** · NA · COMPLETED · sponsor: **Ondokuz Mayıs University** · enrollment: 148 (actual)

## Conditions studied

- Intensive Care Unit Acquired Weakness
- Sepsis, Severe

## Interventions

- **DEVICE:** NMES GROUP

## Key facts

- **NCT ID:** NCT04833621
- **Lead sponsor:** Ondokuz Mayıs University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-23
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04833621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04833621, "Is NMES Treatment in Sepsis/ Septic Shock Patients Protective in Development of ICU-AW?". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04833621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*